1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: 6304, G-04-003, NCT00194714
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-97-C-0118, NCI-T97-0009, T97-0009
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6166, NCI-2010-00803, BC 030289, 120, UWCC-6166, UWCC-UW-6166, UWCC-120, UWCC-04-0951-A-01, NCT00369525, NCT00343109
|
|
4.
|
Phase: Phase I Type: Treatment Status: Closed Age: pre or postmenopausal Sponsor: Other Protocol IDs: UW-100.1, NCI-V97-1259, NCT00003002
|
|
5.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MCV-MCC-9809-1B, NCI-T98-0073
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: UWASH-103, NCI-V99-1574, NCT00005023
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: CWRU-030339, PHARMEXA-PMXA-1103, PHARMEXA-PX104.1.6-101, NCT00068614
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000589446, P30CA015083, MC0338, NCI-2009-01342, 782-05, MAYO-MC0338, NCT00640861
|